Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | tert-Butyldiphenylchlorosilane | HCID 94078 | — |
| Reactant | (S)-(+)-gamma-Hydroxymethyl-gamma-butyrolactone | HCID 2733813 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 66739120 | HCID 66739120 | 97% |
Reaction Steps
To a solution of 3 (7.0 g, 60 mmol) and imidazole (9.19 g, 135 mmol) in anhydrous DMF (70 mL) was added tert-butyldiphenylsilyl chloride (18.14 g, 66 mmol, 17.2 mL), and the solution was stirred at room temperature under a nitrogen atmosphere for 1 h. After removal of the solvent by evaporation, the residue was dissolved in CHCl3, washed with water and brine, dried (Na2SO4), filtered, and concentrated. After crystallization from hexane, the oily residue gave the title compound 4 as a white crystalline solid (20.6 g, 97%). M.P. 76° C.; 1H NMR (CDCl3) δ7.68–7.65 (m, 4H, arom.), 7.47–7.39 (m, 6H, arom.), 4.63–4.61 (m, 1H, H-5), 3.90–3.87 (dd, J=3 & 11 Hz, 1H, CH2OH), 3.70–3.67 (dd, J=3 & 11 Hz, 1H, CH2OH), 2.69–2.65 (m, 1H, H-3), 2.56–2.52 (m, 1H, H-3), 2.32–2.23 (m, 2H, H-4), 1.06 (s, 9H, t-Bu).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07105527B2 |
|---|
| Source dataset | uspto-grants-2006_09 |
|---|
| ORD ID | ord-974edaaeace24eeb8e37a225d258f7c0 |
|---|
| Source note | uspto-grants-2006_09 |
|---|